MYP_161213
Basic Information
Batifiban
Antiplatelet GPIIb IIIa antagonist
Standard
6 amino acids
C28H50N8O9S
Standard
Sequence
NAMINI
Physicochemical Analysis
674.81 Da
5.53
-0.24
-0.44
-0.0400
0.95
0.41
0.41
81.57
146.67
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
295.00
-2.56
9.0
10.0
22.0
46.0
0.0
7.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0149195 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
mixed L/D amino-acid peptide [Mixed]
None
None
1-6
Composite modified token aminoiminomethyl; Composite modified token mercapto; Composite modified token oxopropyl; Composite modified token trypotophyl; Composite modified token prolyl; Composite modified token disulfide
Bio-Activity Profile
Antiplatelet GPIIb IIIa antagonist
HPLC, MS-MS
Human blood plasma (Women) (Intravenous bolus followed by a continuous infusion of batifiban injection), in vivo; 11232 s